{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:08:27Z","timestamp":1791518907932,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["2024LZXNYDJ101"],"award-info":[{"award-number":["2024LZXNYDJ101"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1730"],"award-info":[{"award-number":["2024NSFSC1730"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0626"],"award-info":[{"award-number":["2022YFS0626"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104251"],"award-info":[{"award-number":["82104251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejphar.2025.177320","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T02:36:22Z","timestamp":1738982182000},"page":"177320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The diabetes medication Canagliflozin attenuates alcoholic liver disease by reducing hepatic lipid accumulation via SIRT1-AMPK-mTORC1 signaling pathway"],"prefix":"10.1016","volume":"992","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liaoyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2489-9386","authenticated-orcid":false,"given":"Xuping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177320_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121654","article-title":"Canagliflozin attenuates thioacetamide-induced liver injury through modulation of HMGB1\/RAGE\/TLR4 signaling pathways","volume":"322","author":"Abdelmageed","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177320_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.mito.2021.06.008","article-title":"Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL\/6NCrl mice with high-fat diet\/streptozotocin-induced diabetes mellitus","volume":"59","author":"Belosludtsev","year":"2021","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177320_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat. Protoc."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177320_bib4","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1042\/BCJ20160780","article-title":"The lysosome: a crucial hub for AMPK and mTORC1 signalling","volume":"474","author":"Carroll","year":"2017","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177320_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00204-009-0432-0","article-title":"Role of oxidative stress in alcohol-induced liver injury","volume":"83","author":"Cederbaum","year":"2009","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177320_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40262-014-0190-x","article-title":"Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol)","volume":"53","author":"Chan","year":"2014","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/HEP.0000000000000373","article-title":"Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis","volume":"78","author":"Chao","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/hep.29849","article-title":"DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease","volume":"68","author":"Chen","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177320_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejphar.2025.177320_bib10","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.21037\/jtd.2018.05.92","article-title":"Relationship between free and total malondialdehyde, a well-established marker of oxidative stress, in various types of human biospecimens","volume":"10","author":"Cui","year":"2018","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177320_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40620-020-00845-7","article-title":"SGLT2 inhibitors, sodium and off-target effects: an overview","volume":"34","author":"De Pascalis","year":"2021","journal-title":"J. Nephrol."},{"issue":"2 Suppl. 1","key":"10.1016\/j.ejphar.2025.177320_bib12","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/hep.20957","article-title":"Alcohol and oxidative liver injury","volume":"43","author":"Dey","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177320_bib13","first-page":"22","article-title":"ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review","volume":"30","author":"Eng","year":"2007","journal-title":"Alcohol Res. Health"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1479164114561992","article-title":"Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences","volume":"12","author":"Gallo","year":"2015","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177320_bib16","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/Glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177320_bib17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1258\/ebm.2011.011128","article-title":"The emerging roles of fatty acid translocase\/CD36 and the aryl hydrocarbon receptor in fatty liver disease","volume":"236","author":"He","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177320_bib18","doi-asserted-by":"crossref","first-page":"e0045","DOI":"10.1097\/HC9.0000000000000045","article-title":"Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1\/2 pathway","volume":"7","author":"Huang","year":"2023","journal-title":"Hepatol. Commun."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177320_bib19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.cmet.2023.05.001","article-title":"Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity","volume":"35","author":"Jenkins","year":"2023","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177320_bib20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1194\/jlr.R119000547","article-title":"Alcohol effects on hepatic lipid metabolism","volume":"61","author":"Jeon","year":"2020","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177320_bib21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbadis.2018.05.019","article-title":"Anatomy of rodent and human livers: what are the differences?","volume":"1865","author":"Kruepunga","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177320_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2011.01043.x","article-title":"Sensing damage by the NLRP3 inflammasome","volume":"243","author":"Leemans","year":"2011","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177320_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cld.2018.09.013","article-title":"Alcohol-associated cirrhosis","volume":"23","author":"Lucey","year":"2019","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177320_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0040-1715446","article-title":"Aging and chronic liver disease","volume":"40","author":"Maeso-D\u00edaz","year":"2020","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177320_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cld.2024.06.005","article-title":"Pathogenesis of alcohol-associated liver disease","volume":"28","author":"Mandrekar","year":"2024","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177320_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.ejphar.2025.177320_bib27","doi-asserted-by":"crossref","first-page":"18361","DOI":"10.1074\/jbc.M100655200","article-title":"Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane","volume":"276","author":"Mikhailov","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177320_bib28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1530-0277.2010.01399.x","article-title":"Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines","volume":"35","author":"Miller","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.35946\/arcr.v37.2.08","article-title":"The role of innate immunity in alcoholic liver disease","volume":"37","author":"Nagy","year":"2015","journal-title":"Alcohol Res. Curr. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177320_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","article-title":"SGLT2i: beyond the glucose-lowering effect","volume":"19","author":"Ni","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177320_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177320_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101613","article-title":"SGLT2i reduces renal injury by improving mitochondrial metabolism and biogenesis","author":"Peng","year":"2022","journal-title":"Mol. Metabol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1530-0277.2008.00827.x","article-title":"Molecular mechanisms of alcoholic fatty liver","volume":"33","author":"Purohit","year":"2009","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177320_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12964-021-00706-1","article-title":"Interactions among mTORC, AMPK and SIRT: a computational model for cell energy balance and metabolism","volume":"19","author":"Sadria","year":"2021","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177320_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5009\/gnl11031","article-title":"Erratum: pathophysiology and management of alcoholic liver disease: update 2016","volume":"11","author":"Stickel","year":"2017","journal-title":"Gut Liver"},{"issue":"8","key":"10.1016\/j.ejphar.2025.177320_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10081166","article-title":"Emergence of SGLT2 inhibitors as powerful antioxidants in human diseases","volume":"10","author":"Tsai","year":"2021","journal-title":"Antioxidants"},{"issue":"19\u201320","key":"10.1016\/j.ejphar.2025.177320_bib37","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1101\/gad.339895.120","article-title":"AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation","volume":"34","author":"Van Nostrand","year":"2020","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177320_bib38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/apt.13164","article-title":"Review article: alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease","volume":"41","author":"Vassallo","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1874473710666170125151410","article-title":"A review on the sex differences in organ and system pathology with alcohol drinking","volume":"9","author":"Vatsalya","year":"2016","journal-title":"Curr. Drug Abuse Rev."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177320_bib40","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metabol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177320_bib41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1742-4658.2011.08010.x","article-title":"Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins","volume":"278","author":"Wu","year":"2011","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177320_bib42","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/bph.15381","article-title":"Inhibition of the sodium-glucose co-transporter SGLT2 by canagliflozin ameliorates diet-induced obesity by increasing intra-adipose sympathetic innervation","volume":"178","author":"Yang","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020774","article-title":"Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease","volume":"23","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","article-title":"Effect of ethanol on lipid metabolism","volume":"70","author":"You","year":"2019","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177320_bib45","first-page":"88","article-title":"Sirtuin 1 signaling and alcoholic fatty liver disease","volume":"4","author":"You","year":"2015","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.ejphar.2025.177320_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.redox.2017.09.018","article-title":"Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver","volume":"14","author":"Zeng","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2025.177320_bib47","article-title":"The role of mitochondria in liver ischemia-reperfusion injury: from aspects of mitochondrial oxidative stress, mitochondrial fission, mitochondrial membrane permeable transport pore formation, mitophagy, and mitochondria-related protective measures","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2025.177320_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108712","article-title":"Emerging roles of Sirtuins in alleviating alcoholic liver Disease: a comprehensive review","volume":"108","author":"Zhao","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.177320_bib49","article-title":"Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression","author":"Zhao","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2025.177320_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.138192","article-title":"Drp1\/Mff signaling pathway is involved in fluoride-induced abnormal fission of hepatocyte mitochondria in mice","volume":"725","author":"Zhou","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ejphar.2025.177320_bib51","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.2147\/DDDT.S388823","article-title":"Canagliflozin attenuates hepatic steatosis and atherosclerosis progression in western diet-fed ApoE-knockout mice","volume":"16","author":"Zuo","year":"2022","journal-title":"Drug Des. Dev. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:56:05Z","timestamp":1777395365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"alternative-id":["S0014299925000731"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177320","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diabetes medication Canagliflozin attenuates alcoholic liver disease by reducing hepatic lipid accumulation via SIRT1-AMPK-mTORC1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177320"}}